Redfern, Australia

Daniel Mark Livolsi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Mark Livolsi

Introduction

Daniel Mark Livolsi is an accomplished inventor based in Redfern, Australia. He has made significant contributions to the field of medical technology, particularly in the tracking of medical device usage. With a total of 2 patents to his name, Livolsi's work is focused on enhancing compliance and reporting in medical device applications.

Latest Patents

Livolsi's latest patents include a system and method for tracking medical device usage. This innovative system provides medical device data to users in a user-friendly format. The data is represented as icons that indicate whether the medical device user is compliant or non-compliant with a predetermined set of usage criteria. Compliance is calculated based on the usage data provided by the medical device. Users can select one of the icons to generate a compliance report, which can then be transmitted to a reimbursing entity.

Career Highlights

Daniel Mark Livolsi is currently employed at ResMed Limited, a company known for its focus on innovative solutions in the medical field. His work at ResMed has allowed him to develop technologies that improve patient outcomes and streamline medical device usage.

Collaborations

Livolsi collaborates with talented professionals in his field, including coworkers Natalie Zotelo and Peter Delangre. Their combined expertise contributes to the advancement of medical technology and the development of effective solutions for healthcare providers.

Conclusion

Daniel Mark Livolsi's contributions to medical device technology through his patents and work at ResMed Limited highlight his commitment to innovation in healthcare. His inventions are paving the way for improved compliance tracking and reporting in medical device usage.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…